Patents by Inventor Marco Baratella

Marco Baratella has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10221132
    Abstract: The present invention relates to a process for the synthesis of cysteamine or a salt thereof.
    Type: Grant
    Filed: October 20, 2017
    Date of Patent: March 5, 2019
    Assignee: CHEMELECTIVA SRL
    Inventors: Marco Baratella, Mauro Gaboardi, Graziano Castaldi, Erminio Oldani
  • Patent number: 10112967
    Abstract: A process for the synthesis of Sofosbuvir is provided comprising the steps of selectively mono-deacetylating a compound of formula (V) enzymatically using a resin supported lipase B derived from Candida Antarctica to obtain a compound formula (IV), then converting the compound of formula (IV) to a compound of formula (II) by reacting the compound of formula (IV) with a compound of formula (III), and then converting the compound of formula (II) to Sofosbuvir of formula (I) by deacetylation reaction.
    Type: Grant
    Filed: November 22, 2016
    Date of Patent: October 30, 2018
    Assignee: HC-PHARMA AG
    Inventors: Mauro Gaboardi, Giuseppe Pallanza, Marco Baratella, Graziano Castaldi, Marta Castaldi
  • Publication number: 20180111897
    Abstract: The present invention relates to a process for the synthesis of cysteamine or a salt thereof.
    Type: Application
    Filed: October 20, 2017
    Publication date: April 26, 2018
    Inventors: Marco BARATELLA, Mauro GABOARDI, Graziano CASTALDI, Erminio OLDANI
  • Patent number: 9845289
    Abstract: A process for the synthesis of Dapsone and intermediates thereof are described.
    Type: Grant
    Filed: July 29, 2015
    Date of Patent: December 19, 2017
    Assignee: SEEGPHARM SA
    Inventors: Marco Baratella, Graziano Castaldi, Marta Castaldi, Mauro Gaboardi, Giuseppe Pallanza
  • Publication number: 20170247404
    Abstract: The present invention relates to a process for the synthesis of Sofosbuvir.
    Type: Application
    Filed: November 22, 2016
    Publication date: August 31, 2017
    Inventors: Mauro GABOARDI, Giuseppe PALLANZA, Marco BARATELLA, Graziano CASTALDI, Marta CASTALDI
  • Publication number: 20170217883
    Abstract: A process for the synthesis of Dapsone and intermediates thereof are described.
    Type: Application
    Filed: July 29, 2015
    Publication date: August 3, 2017
    Inventors: Marco BARATELLA, Graziano CASTALDI, Marta CASTALDI, Mauro GABOARDI, Giuseppe PALLANZA
  • Patent number: 9428468
    Abstract: A process for the preparation of Erlotinib is disclosed in which the compound of formula (II) Is reacted with the compound of formula (III) in the presence of trifluoroacetic acid and formamidine acetate, in an aprotic solvent, and the reaction product is subsequently treated with a source of hydrochloric acid in a suitable solvent to give Erlotinib hydrochloride.
    Type: Grant
    Filed: October 27, 2015
    Date of Patent: August 30, 2016
    Assignee: CERBIOS-PHARMA SA
    Inventors: Marco Baratella, Giuseppe Pallanza, Mauro Gaboardi, Graziano Castaldi
  • Publication number: 20160115137
    Abstract: A process for the preparation of Erlotinib is disclosed in which the compound of formula (II) Is reacted with the compound of formula (III) and the reaction product is subsequently treated with a source of hydrochloric acid in a suitable solvent to give Erlotinib hydrochloride.
    Type: Application
    Filed: October 27, 2015
    Publication date: April 28, 2016
    Inventors: Marco BARATELLA, Giuseppe PALLANZA, Mauro GABOARDI, Graziano CASTALDI
  • Patent number: 9216955
    Abstract: The present invention relates to a novel polymorphic form of Fexofenadine hydrochloride, to a process for preparing it, to pharmaceutical compositions containing it, as well as its use. The invention also relates to intermediates useful for the preparation of Fexofenadine hydrochloride, antihistamine drug used in the treatment of allergy symptoms.
    Type: Grant
    Filed: June 15, 2010
    Date of Patent: December 22, 2015
    Assignee: CHEMELECTIVA S.R.L.
    Inventor: Marco Baratella
  • Publication number: 20130237709
    Abstract: Intermediates useful for the synthesis of fexofenadine, processes for their preparation and processes for the synthesis of fexofenadine are described.
    Type: Application
    Filed: February 21, 2013
    Publication date: September 12, 2013
    Applicant: CHEMELECTIVA S.r.l.
    Inventors: Graziano CASTALDI, Marco BARATELLA, Mauro GABOARDI
  • Publication number: 20130059886
    Abstract: The present invention relates to a novel polymorphic form of Fexofenadine hydrochloride, to a process for preparing it, to pharmaceutical compositions containing it, as well as its use. The invention also relates to intermediates useful for the preparation of Fexofenadine hydrochloride, antihistamine drug used in the treatment of allergy symptoms.
    Type: Application
    Filed: June 15, 2010
    Publication date: March 7, 2013
    Applicant: CHEMELECTIVA S.R.L.
    Inventor: Marco Baratella